What to expect when starting a Buprenorphine regimen:
Clients starting a buprenorphine treatment regimen will need to complete a comprehensive clinical assessment with a licensed prescriber to explore options and determine the best course of treatment for that individual client. The client will also undergo a comprehensive clinical assessment by a masters-level counselor to determine if additional services and support functions are indicated.
When starting buprenorphine for the first time, an induction period must be completed under medical supervision to ensure that there are no adverse reactions to the medication. Patients should work with Root Center’s caring and compassionate staff to create a comprehensive treatment plan, which could include titration off other opioids prior to induction and/or microdosing.
As with all medications in MAT programs, buprenorphine is used as part of a comprehensive treatment plan that includes group therapy, individual therapy, and a focus on developing a solid social support network. Each client using buprenorphine will work closely with their counselor and prescriber to monitor cravings and side effects and ensure proper dosing.
Compliance with dosing is essential. Buprenorphine should never be shared or acquired from an unofficial source. Other drugs, alcohol, or unapproved medications should never be taken during a buprenorphine regimen. Buprenorphine may be a safe option for pregnant women with OUD. Please consult with your physician to discuss treatment options and find the best plan for you.
Clients who are interested in switching from methadone to buprenorphine should consult with their counselor and prescriber to discuss the best way to approach the process. When discontinuing or reducing buprenorphine dosage, close consultation and collaboration with the prescriber is essential to ensure a smooth and gradual transition and minimize withdrawals and adverse side effects. This is critical in preventing relapse during transition periods.
